Clinical Trial Update: A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase I study of GLR2037 in advanced prostate cancer has been announced. The trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GLR2037

Snippet

Sponsor: Gan & Lee Pharmaceuticals. | Conditions: Prostate Cancer | Phase 1 | Status: NOT_YET_RECRUITING